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Abstract
Imprinting effects can lead to parent-of-origin patterns in many complex human diseases. For hypertension,
previous studies revealed the possible involvement of imprinted genes. Genetic Analysis Workshop 18 real data,
with hypertensive phenotype and genotype of more than 1000 individuals from 20 pedigrees, provided us an
opportunity to further substantiate such findings. To test for imprinting effects, we developed a pedigree-parental-
asymmetry test taking both affected and unaffected offspring into consideration (PPATu). We carried out a
simulation study based on the Genetic Analysis Workshop 18 pedigrees to show that PPATu has well-controlled
type I error and is indeed more powerful than the pedigree-parental-asymmetry test (PPAT), an existing method
that does not utilize information from unaffected offspring. We then applied PPATu to Genetic Analysis Workshop
18 genome-wide association study data from 20 pedigrees. We identified a number of single-nucleotide
polymorphisms showing significant imprinting effects that are within genomic regions that have been previously
implicated to be associated with hypertension.
Background
Genomic imprinting refers to the phenomenon of unequal
expression of a heterozygous genotype depending on
which parent (father or mother) the imprinted variant is
inherited from. It is estimated that approximately 1% of all
mammalian genes are imprinted (http://igc.otago.ac.nz).
Among these imprinted genes, Beckwith-Wiedemann syn-
drome, Silver-Russell syndrome, Angelman syndrome, and
Prader-Willi syndrome are the best known.
Numerous methods have been proposed to detect
imprinting effects. For a diallelic genetic marker locus,
the parental-asymmetry test (PAT) that considers imbal-
ance of parental origins of the variant allele is simple and
powerful. A series of generalizations of PAT, such as the
pedigree-parental-asymmetry test (PPAT) for general
pedigree data, widen its practical range [1]. However,
these tests use only information on affected offspring and
their parents. Recently, PATu [2] was proposed to take
unaffected offspring in a nuclear family into considera-
tion, making fuller use of data to improve power. In this
study, we propose a novel parent-of-origin effects test,
PPATu, that uses both affected and unaffected offspring
in general pedigrees, and apply the method to the
Genetic Analysis Workshop 18 (GAW18) data, consisting
of 20 large pedigrees, to study the hypertensive pheno-
type. Previous studies revealed the possible involvement
of imprinted genes in hypertension [3,4]. The GAW18
data thus provide us the opportunity to further substanti-
ate such findings.
Methods
Suppose that the marker of interest has 2 alleles, M1
and M2, and the disease allele is more likely to be asso-
ciated with marker allele M1. Let 0, 1, and 2 represent
the marker genotypes M2M2, M1M2, and M1M1, respec-
tively. For a child-parents trio, let F, M, and C denote
the marker genotypes of the father, mother, and child,
respectively. Throughout this article, mating symmetry
is assumed; that is, P(F=f, M=m)=P(F=m, M=f) for all f,
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m = 0,1,2. We also assume that there is no maternal
effect; that is, the maternal genotype does not confer
additional risk on the child’s phenotype.
Suppose we have N independent pedigrees, and for
the ith pedigree, we have nui unaffected and nai affected










where I is the usual indicator function. We can prove
that under the null hypothesis of no imprinting effect, E
















the N(0, 1) distribution asymptotically. When there is
maternal imprinting effect, PPATu will be positive; when
there is paternal imprinting effect, it will be negative.
Note that the contributions from trios in a pedigree are
not independent, and their correlations are accounted for
in the variance. In our simulation study and application
below, we compare the performance of PPATu with
PPAT, whose statistic is defined without the negative
terms in the S statistic; that is, without utilizing informa-
















To evaluate the power of the proposed statistic and to
compare with PPAT, we carried out a simulation study
under 9 different settings, combinations of 3 sets of hap-
lotype frequencies (H1, H2, H3) and 3 imprinting mod-
els (I1, I2, I3) (Table 1). Our data were simulated based
on the general pedigrees from GAW18; their sizes are
described below. To gauge the type I error rate, we also
considered 9 additional settings, combinations of the
same 3 sets of haplotype frequencies and 3 no-imprint-
ing models (N1, N2, N3), also given in Table 1. We
simulated 1000 replicates under each of the settings (a
total of 18 combinations). The results are plotted in
Figure 1, which shows that the empirical type I error
rates, at the 0.01 nominal significance level, are all well
controlled for both PPAT and PPATu. On the other
hand, PPATu is clearly more powerful in all settings,
especially when there is a substantial imprinting effect.
Conclusions are the same for significance levels 0.05
and 0.005 as well; consequently,the results are not
shown for brevity.
GAW18 data analysis
We consider GAW18 real genome-wide association stu-
dies pedigree data that contain a total of 472,049 single-
nucleotide polymorphism (SNP) genotypes on odd chro-
mosomes and phenotype data, including systolic and dia-
stolic blood pressure (SBP and DBP). In our study, we
use a hypertensive binary phenotype; an individual is
classified as affected if SBP > 140 mm Hg, or DBP > 90
mm Hg, or on antihypertensive medication at the first
examination. There are 20 pedigrees; the sizes range
from 27 to 107 individuals. In total, there are only 157
affected offspring, while there are 709 unaffected ones.
Hence, based on the experience gained in our simulation,
we expect a substantial gain in information for PPATu
that makes use of information from both affected and
unaffected individuals when compared to PPAT. To
reduce the effect of multiple testing, we first used pedi-
gree disequilibrium test (PDT [5]) to identify SNPs that
are associated with hypertension at the 0.05 level, and
then performed imprinting effect tests, focusing only on
those SNPs. In our analysis, all trios with complete data
within each pedigree were included in computing the test
statistic. Furthermore, although many tests were per-
formed, we did not attempt to correct for multiple testing
given the small sample size (a total of only 20 pedigrees).
Table 2 shows the cross-classification of SNPs by dif-
ferent tests. We also provide Figure 2, which shows the
results for a combination of significant levels. As one
can see from Figure 2 and Table 2, PPATu detected
more SNPs with smaller p values than PPAT. For SNPs
detected by both methods, the results for PPATu are
more significant. Table 3 shows the 2 SNPs (rs12947636
and rs1674137) that are significant at the 0.01 level for
Table 1 Combinations of 9 imprinting settings and 9 no-imprinting settings
Haplotype frequencya Imprinting modelb No-imprinting modelb
DM1 dM1 DM2 dM2 ϕd/d ϕd/D ϕD/d ϕD/D ϕd/d ϕd/D ϕD/d
H1 0.2 0.0 0.1 0.7 I1 0.26 0.28 0.37 0.39 N1 0.26 0.33 0.39
H2 0.3 0.1 0.0 0.6 I2 0.24 0.26 0.42 0.44 N2 0.24 0.34 0.44
H3 0.3 0.0 0.0 0.7 I3 0.18 0.23 0.53 0.58 N3 0.18 0.38 0.58
aHaplotype frequencies are between disease susceptibility locus(with disease allele D and normal allele d) and marker locus (alleles M1 and M2).
bImprinting models are defined in terms of penetrance probabilities: (jd/d, jd/D, jD/d, jD/D). For the no-imprinting models,jD/d = jd/D.
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both PDT and PPATu. It appears that these 2 SNPs are
novel, as they were not previously identified as asso-
ciated with hypertension, thus further study is warranted
to substantiate the finding.
To gain a more global view of the extent of the role of
imprinting in hypertension, we also carried out genome-
wide testing for imprinting effects without restricting to
SNPs with small p values from PDT. The analysis has
resulted in larger sets with p values smaller than 0.05,
which we call “significant"for easy reference. A search in
the NCBI database found 49 genes implicated to be asso-
ciated with hypertension in previous studies. Figure 3
gives the numbers of SNPs with significant imprinting or
association effects within these genes. We can see that
more SNPs identified by PPATu are within these genes
than those identified by PPAT. Specifically, 47 and 15
SNPs within these genes are identified as having signifi-
cant imprinting effects by PPATu and PPAT, respec-
tively. In fact, the proportion of SNPs identified by
PPATu that are in known genes is higher (1.5 times)
than that identified by PPAT, although this difference is
not substantial. Other than 1 SNP, the rest did not reach
the threshold of significance for PDT, which may be
explained by the power loss of association tests like PDT
that do not account for the imprinting effect properly.
The 1 SNP (rs11606492; Table 3) that yielded significant
results from both PDT and PPATu (but not PPAT) is
within the gene PLEKHA7 that has been implicated to be
associated with hypertension in previous studies [6,7].
Conclusions
In this article, we propose an imprinting test that uti-
lizes both affected and unaffected individuals from
Figure 1 Type I error and power for PPATu and PPAT. The solid
horizontal line marks the nominal significance level of 0.01. For power,
the 9 settings are the 9 combinations of haplotype frequencies and
imprinting models (as given in Table 1): 1 = (H1, I1), 2 = (H2, I1), 3 =
(H3, I1), 4 = (H1, I2), 5 = (H2, I2), 6 = (H3, I2), 7 = (H1, I3), 8 = (H2, I3),
and 9 = (H3, I3). For type I error, the 9 settings are the 9 combinations
of haplotype frequencies and the no-imprinting models (as given in
Table 1): 1 = (H1, N1), 2 = (H2, N1), 3 = (H3, N1), 4 = (H1, N2), 5 = (H2,
N2), 6 = (H3, N2), 7 = (H1, N3), 8 = (H2, N3), and 9 = (H3, N3).
Table 2 Cross-classification of results based on p values
fromassociation(PDT) andimprinting (PPAT and PPATu)
tests
PPAT PPATu
PDT <0.05 <0.01 >0.05 <0.05 <0.01 >0.05
<0.05 245 1 12,752 556 59 12,441
<0.01 17 0 798 30 2 785
>0.05 7008 35 14,681 15,007 1328 6682
Figure 2 Significant imprinting results (p value < 0.05) for SNPs having small p values for association test (815 SNPs with p value <
0.01) across all odd chromosomes. (Top) Based on PPAT that uses only affected off spring and their parent data (17 SNPs identified). (Bottom)
Based on PPATu that uses both affected and unaffected off spring (30 SNPs identified).
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general pedigrees, the type of data provided by GAW18.
We expect PPATu to be more powerful than the existing
test PPAT [1] because the former makes full use of infor-
mation by taking unaffected offspring into consideration.
Indeed, our simulation study shows that PPATu has
higher power than PPAT without an elevated type I error
rate based on the GAW18 pedigrees. Our results from
analysis of the GAW18 data using PPATu leads to the
identification of a number of SNPs that are within geno-
mic regions previously implicated for the hypertensive
phenotype. Nevertheless, further investigation is warranted
especially to evaluate the performance of the methods
under different study designs and ascertainment criteria.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LS designed the overall study; FZ conducted statistical analyses and drafted
the manuscript. Both authors wrote, read, and approved the final
manuscript.
Acknowledgements
The authors would like to acknowledge the NIH grant that supports GAWs
and the GAW18 data providers. This work was supported in part by NSF
grant DMS 1208928.
The GAW18 whole genome sequence data were provided by the T2D-
GENES Consortium, which is supported by NIH grants U01 DK085524, U01
DK085584, U01 DK085501, U01 DK085526, and U01 DK085545. The other
genetic and phenotypic data for GAW18 were provided by the San Antonio
Family Heart Study and San Antonio Family Diabetes/Gallbladder Study,
which are supported by NIH grants P01 HL045222, R01 DK047482, and R01
DK053889. The Genetic Analysis Workshop is supported by NIH grant R01
GM031575.
This article has been published as part of BMC Proceedings Volume 8
Supplement 1, 2014: Genetic Analysis Workshop 18. The full contents of the
supplement are available online at http://www.biomedcentral.com/bmcproc/
supplements/8/S1. Publication charges for this supplement were funded by
the Texas Biomedical Research Institute.
Published: 17 June 2014
References
1. Zhou JY, Ding J, Fung WK, Lin S: Detection of parent-of-origin effects
using general pedigree data. Genet Epidemiol 2010, 34:151-158.
2. Zhou JY, Mao WG, Li DL, Hu YQ, Xia F, Fung WK: A powerful parent-of-
origin effects test for qualitative traits incorporating control children in
nuclear families. J Hum Genet 2012, 57:500-507.
3. Yang J, Lin S: Detection of imprinting and heterogeneous maternal
effects on high blood pressure using Framingham Heart Study data.
BMC Proc 2009, 3(Suppl 7):S125.
4. Yang J, Lin S: Likelihood approach for detecting imprinting and in utero
maternal effects using general pedigrees from prospective family-based
association studies. Biometrics 2012, 68:477-485.
5. Zhou JY, Hu YQ, Lin S, Fung WK: Detection of parent-of-origin effects
based on complete and incomplete nuclear families with multiple
affected children. Hum Hered 2009, 67:1-12.
6. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL,
Morrison AC, Johnson AD, Aspelund T, et al: Genome-wide association
study of blood pressure and hypertension. Nat Genet 2009, 41:677-687.
7. Lin Y, Lai X, Chen B, Xu Y, Huang B, Chen Z, Zhu S, Yao J, Jiang Q,
Huang H, et al: Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are
associated with blood pressure and/or hypertension in She ethnic
minority of China. Atherosclerosis 2011, 219:709-714.
doi:10.1186/1753-6561-8-S1-S52
Cite this article as: Zhang and Lin: Detection of imprinting effects for
hypertension based on general pedigrees utilizing all affected and
unaffected individuals. BMC Proceedings 2014 8(Suppl 1):S52.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Table 3 SNPs having p values <0.05 for both association and imprinting tests
SNP Chr Gene Position P_PDT P_PPAT P_PPATu Imprinting
rs12947636 17 SLC39A11 70992565 0.0090 0.6171 0.0080 maternal
rs1674137 19 TSKS 50258030 0.0089 0.6547 0.0038 maternal
rs11606492 11 PLEKHA7 17000241 0.0488 0.1797 0.0176 paternal
The first 2 SNPs are significant at the 0.01 level for PDT and PPATu. The third SNP is significant at the 0.05 level for PDT and PPATu, and is within the PLEKHA7
gene previously identified as associated with hypertension.
Figure 3 Number of SNPs with significant imprinting or
association effects (p value < 0.05) that are with in genes
previously identified as associated with hypertension. The pink,
yellow, and blue circles denote results from PDT, PPAT, and PPATu,
respectively.
Zhang and Lin BMC Proceedings 2014, 8(Suppl 1):S52
http://www.biomedcentral.com/1753-6561/8/S1/S52
Page 4 of 4
